Prnewswire Medrhythms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire medrhythms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Medrhythms Today - Breaking & Trending Today

MedRhythms Initiates Clinical Trial and Expands Pipeline into Acute Stroke


MedRhythms Initiates Clinical Trial and Expands Pipeline into Acute Stroke
News provided by
Share this article
Share this article
PORTLAND, Maine, April 28, 2021 /PRNewswire/ MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, today announced the launch of a clinical trial that will study MR-010, MedRhythms acute stroke asset. The trial will be in partnership with UMass Memorial Healthcare and will examine the impact of MR-010 on acute stroke walking outcomes.
Stroke is the world s top cause of long-term disability due to the high prevalence of stroke across the globe as well as its devastating health impacts. Over a third of stroke survivors live in the United States and, according to the CDC, approximately 800,000 people in the US suffer a stroke annually. ....

United States , Prnewswire Medrhythms , Brian Harris , Department Of Neurology , Boston University , Memorial Health Care , Brian Silver , Interim Chair , Cleveland Clinic , Spaulding Rehabilitation Hospital , World Report , ஒன்றுபட்டது மாநிலங்களில் , பிரையன் ஹாரிஸ் , துறை ஆஃப் நரம்பியல் , போஸ்டன் பல்கலைக்கழகம் , நினைவகம் ஆரோக்கியம் பராமரிப்பு , பிரையன் வெள்ளி , இடைக்கால நாற்காலி , கிளீவ்லேண்ட் சிகிச்சையகம் , ஸ்பால்டிங் புனர்வாழ்வு மருத்துவமனை , உலகம் அறிக்கை ,

MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson's Disease and Expands Pipeline to Aging


MedRhythms Launches Clinical Trial of Digital Therapeutic in Parkinson s Disease and Expands Pipeline to Aging
News provided by
Share this article
Share this article
PORTLAND, Maine, April 13, 2021 /PRNewswire/ MedRhythms, a digital therapeutics company building direct stimulation solutions that use clinical-grade sensors, software and music to help restore function lost to neurologic disease or injury, today announced the initiation of a multi-site clinical trial, in collaboration with Boston University and one of the world s leading hospitals, of its pipeline asset MR-005 in Parkinson s disease (PD) as well as the expansion of the company s pipeline into aging with the development of its Aging Scientific Advisory Board (SAB). This follows MedRhythms announcement of the advancement of its pipeline into PD and multiple sclerosis (MS) in 2020 with the initiation of clinical trials and the development of MS and PD SABs. ....

United States , Prnewswire Medrhythms , Brian Harris , Terry Ellis , Kirk Erickson , Alvaro Pascual Leone , Joe Verghese , Sidney Wolk Center , Memory Health , Boston University , Boston University Center , Professor Of Neurology At Harvard Medical School , Sargent College , University Of Pittsburgh , Boston University Neurologic Physical Therapy Residency Program , Aging Scientific Advisory Board , Physical Therapy , Athletic Training , Boston University College , Rehabilitation Sciences , Neurologic Physical Therapy Residency Program , Rhythmic Auditory Stimulation , Aging Scientific Advisory , Neurology Division , Motor Aging , Pearl Resnick Gerontology Center ,